IDEXX Laboratories (NASDAQ: IDXX) EVP reports new equity grants and RSU vesting
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
IDEXX Laboratories Executive Vice President Michael Schreck reported a series of equity compensation transactions. On February 12, 2026, he was granted 4,625 non-qualified stock options and 162 incentive stock options, along with 1,094 and 1,620 restricted stock units (RSUs), all at a stated price of 0.0000 per share. Footnotes state these options become exercisable in installments beginning February 14, 2027 and on February 14, 2030, while the RSUs vest over three or four annual installments starting February 14, 2027 and February 14, 2026.
On February 14, 2026, multiple RSU awards vested and were converted into an aggregate of 1,959 shares of common stock at a stated price of 0.0000 per share. In a separate transaction coded “F,” 876 common shares at 629.35 per share were disposed of to satisfy tax withholding, leaving 3,088.709 common shares owned directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
1,959 shares exercised/converted
Mixed
15 txns
Insider
Schreck Michael
Role
Executive Vice President
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit | 117 | $0.00 | -- |
| Exercise | Restricted Stock Unit | 169 | $0.00 | -- |
| Exercise | Restricted Stock Unit | 301 | $0.00 | -- |
| Exercise | Restricted Stock Unit | 367 | $0.00 | -- |
| Exercise | Restricted Stock Unit | 1,005 | $0.00 | -- |
| Exercise | Common Stock | 117 | $0.00 | -- |
| Exercise | Common Stock | 169 | $0.00 | -- |
| Exercise | Common Stock | 301 | $0.00 | -- |
| Exercise | Common Stock | 367 | $0.00 | -- |
| Exercise | Common Stock | 1,005 | $0.00 | -- |
| Tax Withholding | Common Stock | 876 | $629.35 | $551K |
| Grant/Award | Non-Qualified Stock Option (right-to-buy) | 4,625 | $0.00 | -- |
| Grant/Award | Incentive Stock Option (right-to-buy) | 162 | $0.00 | -- |
| Grant/Award | Restricted Stock Unit | 1,094 | $0.00 | -- |
| Grant/Award | Restricted Stock Unit | 1,620 | $0.00 | -- |
Holdings After Transaction:
Restricted Stock Unit — 0 shares (Direct);
Common Stock — 2,122.709 shares (Direct);
Non-Qualified Stock Option (right-to-buy) — 4,625 shares (Direct);
Incentive Stock Option (right-to-buy) — 162 shares (Direct)
Footnotes (1)
- Includes a total of 49.709 shares purchased under the Issuer's Employee Stock Purchase Plan on March 31, 2025, June 30, 2025, September 30, 2025 and December 31, 2025. Closing price of Issuer common stock on Nasdaq Global Select Market on February 13, 2026. Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2027. Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2030. Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning February 14, 2027. Each RSU represents a contingent right to receive one share of Issuer common stock and vests in three annual installments, beginning February 14, 2027. Each RSU represents a contingent right to receive one share of Issuer common stock that vested in four annual installments beginning February 14, 2023. Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments beginning February 14, 2024. Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments beginning February 14, 2025. Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning February 14, 2026. Each RSU represents a contingent right to receive one share of Issuer common stock and vested in one installment on February 14, 2026.
FAQ
What insider transactions did IDEXX (IDXX) Executive Vice President Michael Schreck report?
Michael Schreck reported routine equity compensation activity, including option and restricted stock unit grants on February 12, 2026, and RSU vesting on February 14, 2026. Some resulting common shares were withheld and disposed of to cover associated tax obligations, leaving him directly holding 3,088.709 common shares.
How many stock options were granted to IDEXX (IDXX) EVP Michael Schreck?
Schreck received 4,625 non-qualified stock options and 162 incentive stock options on February 12, 2026. Footnotes explain these options become exercisable in scheduled installments beginning February 14, 2027 and in a single installment on February 14, 2030, subject to their respective vesting terms.
What restricted stock unit awards did IDEXX (IDXX) report for Michael Schreck?
On February 12, 2026, Schreck was granted 1,094 and 1,620 restricted stock units. Each RSU represents a contingent right to receive one IDEXX common share and vests in three or four annual installments beginning February 14, 2027 and February 14, 2026, according to the detailed vesting footnotes.
Are Michael Schreck’s IDEXX (IDXX) equity awards immediately exercisable or fully vested?
No, the newly reported awards vest over time. Option grants begin to become exercisable in annual installments starting February 14, 2027, with one grant exercisable on February 14, 2030. RSU grants vest in three or four annual installments beginning February 14, 2026 and February 14, 2027.